most valuable cryptocurrencies- Top Block

Guolian Securities: The Shanghai Stock Exchange plans to review the acquisition of Minsheng by Guolian on December 17. Guolian Securities announced that the company plans to issue A shares to purchase 99.26% of Minsheng Securities and raise matching funds. This transaction constitutes a major asset reorganization and constitutes a related party transaction, which does not constitute a reorganization and listing. According to the Announcement of the 6th Review Meeting of M&A Review Committee of Shanghai Stock Exchange in 2024, the M&A Review Committee of Shanghai Stock Exchange is scheduled to hold the 6th Review Meeting of M&A Review Committee in 2024 on December 17th, 2024 to review the company's application for this transaction.Belarusian President Lukashenko: Belarus has dozens of nuclear warheads.AstraZeneca's potential blockbuster ADC was recognized by the FDA. AstraZeneca and Thirteen announced that the FDA granted its Trop2 targeted antibody-coupled drug (ADC) Datopotamab Deruxtecan (Dato-DXD) breakthrough therapy recognition (BTD) to treat adult patients with locally advanced or metastatic epidermal growth factor receptor mutation (EGFRm) who are undergoing treatment.

The scale of China's AI core industry is nearly 600 billion yuan. Generative artificial intelligence enterprises set off a price war. According to the Report on the Development of Generative Artificial Intelligence Applications in 2024, as of June, the number of users of China's generative artificial intelligence products has reached 230 million. At present, the number of enterprises has exceeded 4,500, and the scale of core industries is close to 600 billion yuan. According to industry insiders, compared with the input cost of several billion yuan, the large model enterprises are not commercialized at present, and the realization is slow. A large number of generative artificial intelligence enterprises in the market, in order to compete for users, set off a round of computing power price war in the industry, and the price of large model computing power once dropped by as much as 90%. (CCTV Finance)Textile City: It is planned to sign the Entrusted Operation and Management Agreement with related parties. Textile City announced that the company plans to sign the Entrusted Operation and Management Agreement with Shaoxing Keqiao District Development and Management Group Co., Ltd. In 2023, the amount of daily related transactions between the company and the development and operation group was 4,449,600 yuan, and the estimated amount of daily related transactions in 2024 was 4,750,000 yuan. The renovation cost of the exhibition center is about 50 million yuan. After the renovation, it is estimated that about 200 business rooms can be renovated, and the total income during the 20-year operation period is about 994 million yuan.Qatar Foreign Ministry spokesman: We are witnessing a historic moment in the region, which is the light of hope for the Syrian people to realize their ambitions.

Spokesman of the Ministry of Foreign Affairs of Qatar: All doors and communication channels are open for dialogue with Syrian parties on the future of Syria.The Beijing Municipal Science and Technology Commission and Zhongguancun Management Committee investigated the brain-computer interface technology under Chengyitong. Recently, Li Junnan, Minister of the Frontier Department of Medical Center of Beijing Science and Technology Commission and Zhongguancun Management Committee, and Zheng Meng, Deputy Director of Daxing District Science and Technology Commission, and his party went to Beijing Naolin Technology Co., Ltd., a subsidiary of Chengyitong, to have in-depth exchanges on further promoting the development and application of brain-computer interface technology. According to reports, at present, the company has made a series of important technological breakthroughs, and has completed the trial production of three prototypes of nerve rehabilitation products based on brain-computer interface technology, namely, products based on visual evoked potential paradigm-brain-computer interface cognitive rehabilitation system, brain-computer interface hand function rehabilitation system, and innovative mixed paradigm products based on visual reinforcement of motor imagination-brain-computer interface upper and lower limb active and passive rehabilitation system.AstraZeneca's potential blockbuster ADC was recognized by the FDA. AstraZeneca and Thirteen announced that the FDA granted its Trop2 targeted antibody-coupled drug (ADC) Datopotamab Deruxtecan (Dato-DXD) breakthrough therapy recognition (BTD) to treat adult patients with locally advanced or metastatic epidermal growth factor receptor mutation (EGFRm) who are undergoing treatment.